BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
550 results:

  • 1. Temporal trends and regional variability in BRAF and kras genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 3. Circular RNAs in the kras pathway: Emerging players in cancer progression.
    Hussain MS; Moglad E; Afzal M; Bansal P; Kaur H; Deorari M; Ali H; Shahwan M; Hassan Almalki W; Kazmi I; Alzarea SI; Singh SK; Dua K; Gupta G
    Pathol Res Pract; 2024 Apr; 256():155259. PubMed ID: 38503004
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Noninvasive Stratification of Colon cancer by Multiplex PET Imaging.
    Malviya G; Lannagan TRM; Johnson E; Mackintosh A; Bielik R; Peters A; Soloviev D; Brown G; Jackstadt R; Nixon C; Gilroy K; Campbell A; Sansom OJ; Lewis DY
    Clin Cancer Res; 2024 Apr; 30(8):1518-1529. PubMed ID: 38493804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic colorectal cancer: A Multicenter Retrospective Comparative Study.
    Bazarbashi S; Alkhatib R; Aseafan M; Tuleimat Y; Abdel-Aziz N; Mahrous M; Elsamany S; Elhassan T; Alghamdi M
    JCO Glob Oncol; 2024 Mar; 10():e2300461. PubMed ID: 38484194
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
    Kavgaci G; Dizdar O; Yalcin S
    Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
    Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
    Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
    Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
    Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exploring the role of sporadic BRAF and kras mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp.
    Franck S; Eidens M; Fuhrländer J; Ogreid D
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213210
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. kras Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset colorectal cancer.
    Aljehani MA; Bien J; Lee JSH; Fisher GA; Lin AY
    JAMA Netw Open; 2023 Nov; 6(11):e2345801. PubMed ID: 38032636
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Driver gene kras aggravates cancer-associated stroke outcomes.
    Yan H; Sasaki T; Gon Y; Nishiyama K; Kanki H; Mochizuki H
    Thromb Res; 2024 Jan; 233():55-68. PubMed ID: 38029547
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
    Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
    ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. An incidental traditional serrated adenoma of the gallbladder: A case report.
    Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
    Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
    Deboever N; Bayley EM; Eisenberg MA; Hofstetter WL; Mehran RJ; Rice DC; Rajaram R; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Bednarski BK; Morris VK; Antonoff MB
    J Surg Oncol; 2024 Feb; 129(2):331-337. PubMed ID: 37876311
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
    Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
    BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Conditional Overall Survival After diagnosis of Non-Metastatic Colon cancer: Impact of Laterality, MSI, and kras Status.
    Tran CG; Goffredo P; Mott SL; Suraju MO; Kohn JF; Mishra A; Vauthey JN; Hassan I
    Ann Surg Oncol; 2024 Jan; 31(1):142-151. PubMed ID: 37857983
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.